Total Funding
55
50
Total FundingPost-IPO Debt raised
Growth Score
-6 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
228013
TSO3 develops innovative low temperature sterile reprocessing solutions for medical devices.
Marc Boisjoli: CFO- R.M. Rumble: CEO
About the Company
TSO3 develops innovative low temperature sterile reprocessing solutions for medical devices.
Through superior and innovative low-temperature sterile reprocessing solutions for medical devices, we offer sterility and economic efficiency. This means better and more accessible medical care.Founded in 1998, TSO3 originally developed a unique
sterilization process based on only ozone as the sterilizing agent. It offered major savings over competing low-temperature sterilization methods, greater safety for both users and patients, and was considered a “green” technology.
